Vaccine
Vaccines are the most effective agents for preventing infectious diseases. However, for optimal effect it they must be administered correctly at the right time to appropriate groups of the population. The Norwegian Institute of Public Health aims, through its expertise in this area, to ensure that vaccines used in Norway are as effective as possible.
-
The Norwegian Institute of Public Health collaborates closely with the Norwegian Directorate of Health, and is a major contributor to the official information given by Norwegian health authorities. On the national website www.pandemi.no you will find the official information that has been published so far regarding the pandemic flu, in Norwegian as well as in English and several other languages.
Read more [16.11.2009]
-
Chronic human papilloma virus (HPV)-infections can lead to cellular changes in the cervix that can be a pre-stage to cervical cancer. Surgical treatment of these pre-stages gives an increased risk of preterm birth in subsequent pregnancies. As the HPV-vaccine can prevent pre-stages of cervical cancer, it may therefore reduce the number of preterm births. A new Norwegian study has calculated the benefits of HPV-vaccination.
Read more [17.03.2009]
-
The Norwegian Institute of Public Health has brochures about vaccines, vaccine preventable diseases and other health topics in English and other languages.
Les mer [19.12.2008]
-
In 2006, a pneumococcal vaccine (Prevenar®) was introduced in the childhood vaccination programme in Norway. Two years later, the experiences have been published in the journal Vaccine. The results show a strong decline in serious pneumococcal infections among young children.
Read more [09.07.2008]
-
An overview of present and previous childhood immunisation programme in Norway.
More... [01.04.2004, Oppdatert 22.06.2009, 14:01]